Page last updated: 2024-09-04

olmesartan and Tachycardia, Paroxysmal

olmesartan has been researched along with Tachycardia, Paroxysmal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breithardt, G; Fetsch, T; Goette, A; Häusler, KG; Kirchhof, P; Klein, HU; Meinertz, T; Schön, N; Steinbeck, G; Wegscheider, K	1

Trials

1 trial(s) available for olmesartan and Tachycardia, Paroxysmal

Article	Year
Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Germany; Humans; Imidazoles; Incidence; Male; Middle Aged; Prospective Studies; Tachycardia, Paroxysmal; Tetrazoles; Time Factors; Treatment Outcome	2012

Article

Year

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.

Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:1

Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Germany; Humans; Imidazoles; Incidence; Male; Middle Aged; Prospective Studies; Tachycardia, Paroxysmal; Tetrazoles; Time Factors; Treatment Outcome

2012